Potassium Ion

Potassium Ion

SCHEMBL2854671

C[O-].[K+].[NaH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL6839 0.89
Potassium Ion SCHEMBL14634347 0.80
SCHEMBL11789752 0.80
SCHEMBL1190396 0.80
Potassium Ion SCHEMBL339434 0.80
Potassium Ion SCHEMBL4350561 0.80
SCHEMBL11791491 0.80
Potassium Ion SCHEMBL2955595 0.73
Methyl Alcohol SCHEMBL1797215 0.73
SCHEMBL25254193 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117510332-A New method for synthesizing 6, 8-dichloro octanoic acid ester 风火轮(上海)生物科技有限公司 2024-02-06 CN claimed
CN-117088555-A Device and method for preprocessing reactive liquid hazardous waste by utilizing microchannel reactor 光大绿色环保危废处置(临沭)有限公司 2023-11-21 CN claimed
CN-116903500-A Method for synthesizing p-methylsulfonyl benzaldehyde 上海颐碳化学科技有限公司 2023-10-20 CN claimed
CN-116396205-A N-aryl indole derivative and preparation method and application thereof 沈阳药科大学 2023-07-07 CN claimed
EP-1848720-A1 RAPID RESOLUTION PROCESS FOR CLOPIDOGREL BASE AND A PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE POLYMORPH - FORM I USV LIMITED (IN) 2007-10-31 EP claimed
WO-2006087729-A1 RAPID RESOLUTION PROCESS FOR CLOPIDOGREL BASE AND A PROCESS FOR PREPARATION OF CLOPIDOGREL BISULFATE POLYMORPH - FORM I USV LIMITED (IN) 2006-08-24 WO claimed
US-20060074242-A1 Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I USV LIMITED (IN) 2006-04-06 US claimed
CN-117510332-A New method for synthesizing 6, 8-dichloro octanoic acid ester 风火轮(上海)生物科技有限公司 2024-02-06 CN disclosed
US-20240018491-A1 Purified Immobilized Lipases ENZYMOCORE LTD. (IL) 2024-01-18 US disclosed
CN-117088555-A Device and method for preprocessing reactive liquid hazardous waste by utilizing microchannel reactor 光大绿色环保危废处置(临沭)有限公司 2023-11-21 CN disclosed
CN-116903500-A Method for synthesizing p-methylsulfonyl benzaldehyde 上海颐碳化学科技有限公司 2023-10-20 CN disclosed
EP-4256042-A1 PURIFIED IMMOBILIZED LIPASES Enzymocore Ltd. (IL) 2023-10-11 EP disclosed
CN-116396205-A N-aryl indole derivative and preparation method and application thereof 沈阳药科大学 2023-07-07 CN disclosed
US-6800759-B2 REACTING MIXTURE OF (R) AND (S) CLOPIDOGREL FREE BASE WITH LEVOROTATORY CAMPHORSULFONIC ACID IN C5 TO C12 HYDROCARBON TO PRECIPITATE (S) CLOPIDOGREL CAMPHORSULFONATE, CONVERTING TO FREE BASE, PRECIPITATING CLOPIDOGREL BISULFATE IN SOLVENT TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-10-05 US disclosed
US-6737411-B2 CRYSTALLIZING AS CAMPHOR SULFONATE SALT; CONVERTING PURIFIED MATERIAL BACK TO FREE BASE FORM TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-05-18 US disclosed
WO-2004013147-A1 RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-02-12 WO disclosed
US-20040024012-A1 Racemization and enantiomer separation of clopidogrel TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-02-05 US disclosed
US-20040024011-A1 RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL TEVA PHARMACEUTICALS USA, INC. 2004-02-05 US disclosed
US-5446159-A Process for preparing imidazopyridine derivatives LONZA, LTD. (CH) 1995-08-29 US disclosed
US-5446160-A Process for preparing imidazopyridine derivatives LONZA LTD. (CH) 1995-08-29 US disclosed